MedPath

四川彩虹制药有限公司

Ownership
-
Established
1998-10-09
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

61

NMPA:61

Drug Approvals

参柴胶囊

Approval Number
国药准字Z20080119
Approval Date
Dec 28, 2023
NMPA

Compound Hepar Extractum Syrup

Product Name
复方肝浸膏糖浆
Approval Number
国药准字H20067873
Approval Date
Jan 12, 2022
NMPA

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H51020103
Approval Date
May 21, 2021
NMPA

十滴水

Approval Number
国药准字Z20064464
Approval Date
May 10, 2021
NMPA

金银花糖浆

Approval Number
国药准字Z20064463
Approval Date
May 10, 2021
NMPA

苏菲咳糖浆

Approval Number
国药准字Z51020763
Approval Date
Oct 19, 2020
NMPA

消渴灵片

Approval Number
国药准字Z19983099
Approval Date
Jun 15, 2020
NMPA

Etidronate Disodium Tablets

Product Name
邦特林
Approval Number
国药准字H10960307
Approval Date
May 29, 2020
NMPA

复方鱼腥草片

Approval Number
国药准字Z51020759
Approval Date
May 14, 2020
NMPA

维C银翘片

Approval Number
国药准字Z51020764
Approval Date
May 14, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.